EGFR and colorectal carcinoma: In colorectal carcinoma (CRC), TRIP13 interacted with the receptor tyrosine kinase fibroblast growth factor receptor 4 (FGFR4) and activated the epidermal growth factor receptor (EGFR)/AKT pathway to induce EMT [27].